|
|
2025's Stock Market Performance
|
|
2025's Stock Market Performance
|
2025's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2025.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 10/02/26.
2025's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2025 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 10/02/26.
2025's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2025 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 10/02/26.
2025's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2025 with the market capitalization, trading under 50 million U.S. dollars, as of 10/02/26.
| The Best Performing Micro-Cap Stocks in 2025 |
2025 |
| Handeni Gold Inc. | Metal Mining Industry | 66,150.00 % | | Applied Uv Inc | Electric & Wiring Equipment Industry | 39,900.00 % | | Ampio Pharmaceuticals inc | Major Pharmaceutical Preparations Industry | 19,900.00 % | | Clever Leaves Holdings Inc | Major Pharmaceutical Preparations Industry | 9,900.00 % | | Kaleido Biosciences Inc | Biotechnology & Pharmaceuticals Industry | 9,900.00 % | | Mj Holdings Inc | Professional Services Industry | 9,900.00 % | | Uscorp | Metal Mining Industry | 9,900.00 % | | Elys Game Technology Corp | Software & Programming Industry | 4,900.00 % | | Sonendo Inc | Medical Equipment & Supplies Industry | 1,539.34 % | | Aridis Pharmaceuticals Inc | Major Pharmaceutical Preparations Industry | 1,400.00 % | | Eloxx Pharmaceuticals Inc | Biotechnology & Pharmaceuticals Industry | 1,000.00 % | | Bionik Laboratories Corp | Medical Equipment & Supplies Industry | 900.00 % | | Colombia Energy Resources, Inc. | Coal Mining Industry | 900.00 % | | Panex Resources Inc. | Blank Checks Industry | 900.00 % | | Health Discovery Corporation | Conglomerates Industry | 900.00 % | | Ipic Entertainment Inc. | Restaurants Industry | 900.00 % | | Imageware Systems Inc | Software & Programming Industry | 900.00 % | | Rejuvel Bio-sciences, Inc. | Food Processing Industry | 900.00 % | | Renovare Environmental inc. | Educational Services Industry | 900.00 % | | Sunstock Inc | Wholesale Industry | 852.84 % |
Who are the 2025's Stock Market Losers?
IT
-47.80%
|
|
|
Gartner Inc
Internet Services & Social Media Industry
IT
-47.80%
Gartner Inc. operates a business model focused on delivering research and advisory services aimed at helping organizations improve their performance and strategic decision-making. Their revenue is primarily generated through subscription-based access to a comprehensive suite of research reports, expert analyses, and consulting services tailored to various industries.
|
MBLY
-47.85%
|
|
|
Mobileye Global inc
Software & Programming Industry
MBLY
-47.85%
Mobileye Global Inc*s business model revolves around developing and providing advanced driver-assistance systems (ADAS) and autonomous driving technology to automotive manufacturers.
|
CAVA
-49.04%
|
|
|
Cava Group Inc
Restaurants Industry
CAVA
-49.04%
Cava Group Inc operates a fast-casual Mediterranean restaurant chain, offering customizable meals with a focus on fresh and healthy ingredients. The company follows an order-at-the-counter model, providing customers with a variety of options to assemble their own Mediterranean bowls, salads, or pitas.
|
DECK
-49.32%
|
|
|
Deckers Outdoor Corp
Apparel, Footwear & Accessories Industry
DECK
-49.32%
Deckers Outdoor Corp is a footwear and apparel company that operates through a multi-brand business model. They design, manufacture, and distribute various lifestyle and performance products under their owned brands like UGG, Teva, and HOKA ONE ONE. By leveraging their strong brand portfolio, Deckers aims to capture a diverse range of consumer preferences and cater to different market segments within the footwear industry.
|
ARE
-49.81%
|
|
|
Alexandria Real Estate Equities Inc
Real Estate Investment Trusts Industry
ARE
-49.81%
Alexandria Real Estate Equities Inc. operates by acquiring, developing, and managing properties tailored specifically for the life sciences and technology sectors. Their strategy includes creating clustered environments that foster collaboration and innovation, which are appealing to leading companies in these industries. By offering high-quality facilities and comprehensive support services, Alexandria cultivates a vibrant ecosystem conducive to scientific research and development.
|
QFIN
-50.19%
|
|
|
Qfin Holdings Inc
Miscellaneous Financial Services Industry
QFIN
-50.19%
Qifu Technology Inc operates as an e-commerce platform, utilizing technology to connect buyers and sellers within the Chinese market, offering a wide range of products and services through its online marketplace. The company generates revenue primarily through transaction fees, commissions, and advertising.
|
WIX
-52.02%
|
|
|
Wix com Ltd
Internet Services & Social Media Industry
WIX
-52.02%
is a leading global cloud-based web development platform for millions of registered users and creators worldwide
|
RPAY
-52.23%
|
|
|
Repay Holdings Corporation
Professional Services Industry
RPAY
-52.23%
Repay Holdings Corporation*s business model is focused on providing innovative payment technology solutions and services to businesses in various industries.
|
KMX
-52.43%
|
|
|
Carmax Inc
Automotive Aftermarket Industry
KMX
-52.43%
CarMax Inc operates a network of used car dealerships in the U.S. focusing on a streamlined, hassle-free buying and selling experience. They emphasize transparent pricing, extensive vehicle selections, and detailed history reports, catering to both buyers and sellers.
|
NCTY
-57.42%
|
|
|
The9 Ltd
Miscellaneous Financial Services Industry
NCTY
-57.42%
The9 Ltd operates as a diversified online gaming company focusing on game development, esports, and digital content distribution in China.
|
FIG
-64.10%
|
|
|
Figma Inc
Investment Services Industry
FIG
-64.10%
Fortress Investment Group LLC*s business model is centered around diversified and alternative investments. It focuses on managing various asset classes, including private equity, credit, real estate, and permanent capital investment strategies. The company aims to generate consistent and attractive risk-adjusted returns for its investors through strategic investment and active asset management.
|
FISV
-67.39%
|
|
|
Fiserv Inc
Professional Services Industry
FISV
-67.39%
Fiserv offers technology solutions for global payments and financial services.
|
TTD
-67.76%
|
|
|
Trade Desk Inc
Internet Services & Social Media Industry
TTD
-67.76%
is a global technology company that empowers buyers of advertising
|
BLRX
-73.37%
|
|
|
Biolinerx Ltd
Major Pharmaceutical Preparations Industry
BLRX
-73.37%
Biolinerx Ltd is a biopharmaceutical company that focuses on discovering, developing, and commercializing novel therapeutics for various diseases. Their business model revolves around the research and development of innovative drug candidates, conducting clinical trials to assess their safety and efficacy, and obtaining regulatory approvals to bring these treatments to market. They aim to generate revenue through licensing agreements, strategic collaborations, and the sale of their therapeutics to patients or healthcare providers.
|
MODD
-74.18%
|
|
|
Modular Medical Inc
Medical Equipment & Supplies Industry
MODD
-74.18%
Modular Medical Inc operates with a business model focused on designing and manufacturing modular medical units, offering cost-effective and customizable solutions for healthcare providers looking to expand their facilities rapidly and efficiently. They aim to deliver innovative and turnkey solutions that can be easily deployed and scaled to meet the specific needs of their clients.
|
AKTX
-76.12%
|
|
|
Akari Therapeutics Plc
Major Pharmaceutical Preparations Industry
AKTX
-76.12%
Akari Therapeutics Plc is a biopharmaceutical company that develops and commercializes treatments for autoimmune and inflammatory diseases. Their business model revolves around conducting research, clinical trials, and obtaining regulatory approvals for their product candidates. They aim to provide innovative therapies to patients and generate revenue through the sale and licensing of their products.
|
|